Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 7, 2011, Pages 961-968

  Eggel, A ^a   Buschor, P ^a   Baumann, M J ^b   Amstutz, P ^b   Stadler, B M ^a   Vogel, M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b MOLECULAR PARTNERS AG   (Switzerland)

Author keywords

allergy treatment; basophils degranulation; DARPin; Fc receptors; IgE

Indexed keywords

ANTIALLERGIC AGENT; DE53 FC FUSION PROTEIN; OMALIZUMAB; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANAPHYLAXIS; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASOPHIL DEGRANULATION; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOLECULAR LIBRARY; PRIORITY JOURNAL;

ALLERGENS; ANTIBODIES, ANTI-IDIOTYPIC; BASOPHILS; CELL DEGRANULATION; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MUSCLE PROTEINS; NUCLEAR PROTEINS; RECEPTORS, FC; RECEPTORS, IGE; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS;

EID: 79958110928     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02546.x     Document Type: Article

References (27)

1. Galli SJ, Tsai M, Piliponsky AM,. The development of allergic inflammation. Nature 2008; 454: 445-454.
2. Gibbs BF, Räthling A, Zillikens D, Huber M, Haas H,. Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J Allergy Clin Immunol 2006; 118: 1060-1067. (Pubitemid 44755179)
3. Holgate ST, Polosa R,. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008; 8: 218-230. (Pubitemid 351323290)
4. Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C,. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 2005; 115: 459-465. (Pubitemid 40341694)
5. Sullivan SD, Turk F,. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Allergy 2008; 63: 670-684. (Pubitemid 351591863)
6. Kraft S, Kinet J-P,. New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol 2007; 7: 365-378. (Pubitemid 46674486)
7. Daãron M, Malbec O, Latour S, Arock M, Fridman WH,. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995; 95: 577-585.
8. Tam SW, Demissie S, Thomas D, Daeron M,. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 2004; 59: 772-780. (Pubitemid 38850354)
9. Van Scott M, Mertsching E, Negrou E, Miles J, Stallings H, Graff C, et al., Systemic administration of an Fcgamma-Fcepsilon-fusion protein in house dust mite sensitive nonhuman primates. Clin Immunol 2008; 128: 340-348.
10. Wigginton SJ, Furtado PB, Armour KL, Clark MR, Robins A, Emara M, et al., An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb. Clin Exp Allergy 2008; 38: 313-319.
11. Zhu D, Kepley CL, Zhang K, Terada T, Yamada T, Saxon A,. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 2005; 11: 446-449. (Pubitemid 40562337)
12. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A,. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med 2002; 8: 518-521. (Pubitemid 34546756)
13. D'Ambrosio D, Fong DC, Cambier JC,. The SHIP phosphatase becomes associated with Fc gammaRIIB1 and is tyrosine phosphorylated during 'negative' signaling. Immunol Lett 1996; 54: 77-82. (Pubitemid 27088211)
14. Gimborn K, Lessmann E, Kuppig S, Krystal G, Huber M,. SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels. J Immunol 2005; 174: 507-516. (Pubitemid 40007441)
15. Mertsching E, Bafetti L, Hess H, Perper S, Giza K, Allen LC, et al., A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases. J Allergy Clin Immunol 2008; 121: 441-447.
16. DaÃron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, et al., The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995; 3: 635-646.
17. Zahnd C, Amstutz P, Plückthun A,. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat Methods 2007; 4: 269-279. (Pubitemid 46358879)
18. Baumann MJ, Eggel A, Amstutz P, Stadler BM, Vogel M,. DARPins Against a Functional IgE Epitope. Immunol Lett 2010; 133: 78-84.
19. Knol EF, Mul FP, Jansen H, Calafat J, Roos D,. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991; 88 (3 Pt 1): 328-338.
20. Sainte-Laudy J, Sabbah A, Vallon C, Guerin JC,. Analysis of anti-IgE and allergen induced human basophil activation by flow cytometry. Comparison with histamine release. Inflamm Res 1998; 47: 401-408. (Pubitemid 28493283)
21. Szegedi A, Irinyi B, Gál M, Hunyadi J, Dankõ K, Kiss E, et al., Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol 2006; 155: 67-75. (Pubitemid 43876395)
22. Hanes J, Plückthun A,. In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci USA 1997; 94: 4937-4942. (Pubitemid 27214714)
23. Conroy MC, Adkinson NF, Lichtenstein LM,. Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. J Immunol 1977; 118: 1317-1321. (Pubitemid 8085531)
24. Allen LC, Kepley CL, Saxon A, Zhang K,. Modifications to an Fcgamma-Fcvarepsilon fusion protein alter its effectiveness in the inhibition of FcvarepsilonRI-mediated functions. J Allergy Clin Immunol 2007; 120: 462-468. (Pubitemid 47102381)
25. Kepley CL, Taghavi S, Mackay G, Zhu D, Morel PA, Zhang K, et al., Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. J Biol Chem 2004; 279: 35139-35149. (Pubitemid 39100510)
26. Sármay G, Koncz G, Gergely J,. Integration of activatory and inhibitory signals in human B-cells. Immunol Lett 1996; 54: 93-100. (Pubitemid 27086907)
27. Ravetch JV, Bolland S,. IgG Fc receptors. Annu Rev Immunol 2001; 19: 275-290. (Pubitemid 32368037)